True Leaf: Crowdfunding Legal Cannabis Products Across North America


Ryan Allway

September 20th, 2017

Exclusive, News


The North American cannabis industry was worth $6.7 billion in 2016 and is projected to reach $20.2 billion by 2021, according Arcview Market Research, representing a 25% compounded annual growth rate. In addition to federal legalization in Canada, U.S. consumers have become increasingly interested in the potential health benefits of hemp – also known as cannabis sativa, but without the psychoactive elements and the accompanying legal issues.

In this article, we will look at True Leaf Medicine International Ltd. (CSE: MJ) (OTCQB: TRLFF) and its pending Regulation A+ public offering that is giving anyone the opportunity to invest in hemp and cannabis products that will be fully legal in both the U.S. and Canada. True Leaf’s mission is to create safe, natural cannabis based products that enhance the quality of life for both people and pets. The company already has pet products in the market, and is in the final stages of Canadian approval to grow and sell legal cannabis.

“This is a truly unique opportunity for investors to own a piece of a company that produces and distributes cannabis products that are fully legal right now across North America,” says True Leaf CEO and Founder Darcy Bomford. “We’re excited about this opportunity –and we’re excited about the future of True Leaf in the cannabis space.”

Click here for more information regarding the upcoming financing.

Two True Leaf Divisions

True Leaf Pet

Americans will spend nearly $70 billion on their pets this year, according to the American Pet Products Association, including nearly $15 billion in over-the-counter medicine and supplies. At the same time, consumers are increasingly searching for hemp-based products for their pets as an alternative to conventional foods and pharmaceuticals. Only a handful of companies in the space are currently serving this rapidly growing subset of the market.

True Leaf Pet is the first company to combine the beneficial properties of hemp seed with other scientifically proven ingredients to create a line of functional pet products. The company’s widely popular True Hemp™ line of supplements include CALMING, HIP+JOINT and IMMUNE+HEART support products available in soft chews, sticks, and oil formats. These products are already on the market and available for sale in the United States.

True Leaf Medicine

Canada has become a pioneer within the legal cannabis industry following the passing of the Access to Cannabis for Medical Purposes Regulations (ACMPR) and its predecessors. According to Deloitte, Canada’s legal cannabis industry could exceed C$22.6 billion over the coming years, including C$8.7 billion from the retail market each year. Licensed producers represent some of the best opportunities to capitalize on the market.

True Leaf Medicine is seeking a license to sell medical cannabis in Canada under the ACMPR program ahead of federal-level recreational legalization next year. The company’s application has already passed through the preliminary and enhanced screening process and is currently in the approval to build stage of the process. Once the production facility is inspected and approved, the company will be able to grow and sell cannabis into Canada’s market.

The leadership team behind these efforts has significant experience navigating regulatory frameworks and working in manufacturing. Chairman Michael F. Harcourt is the former Premier of British Columbia as well as the former mayor of Vancouver, while CEO Darcy Bomford has 30 years of experience in the pet industry operating manufacturing plants and marketing pet products worldwide. This team is uniquely qualified to execute on the company’s vision over the long-term.

Click here for more information regarding the upcoming financing.

Looking Ahead

True Leaf Medicine International Ltd. (CSE: MJ) (OTCQB: TRLFF) represents a unique opportunity to invest in both the U.S. and Canadian cannabis industry. With products already in the market generating revenue, the company differentiates itself from many development-stage companies in the space, while its diversified operations create an opportunity for superior risk-adjusted returns. Investors may want to take a closer look at the stock sooner rather than later.

“People are looking for natural ways to lead healthy, long lives and they want the same for their pets,” said True Leaf CEO Darcy Bomford. “As attitudes and laws continue to change around hemp and cannabis, True Leaf aims to take the global lead on creating products that improve quality of life for people and pets. We are excited to extend the opportunity to own a piece of True Leaf to customers, supporters, and investors who share our values and enthusiasm.”

True Leaf’s Regulation A+ offering enables investors to gain ground floor exposure to the legal North American cannabis industry. In addition, investors participating in the offering will have access to unique benefits like free trading shares, special shout outs, discounts, products and more. Investors can also invest in the stock through the Canadian Stock Exchange or U.S. OTCQB marketplace.

For more information, visit the company’s website or sign up to keep up to date with the pending financing.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading